603367 Stock Overview
Manufactures and sells chemical drug preparations and health care products in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Cisen Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.36 |
| 52 Week High | CN¥17.45 |
| 52 Week Low | CN¥11.34 |
| Beta | 0.24 |
| 11 Month Change | 10.78% |
| 3 Month Change | -1.47% |
| 1 Year Change | 4.05% |
| 33 Year Change | 10.87% |
| 5 Year Change | -11.11% |
| Change since IPO | -20.43% |
Recent News & Updates
Shareholder Returns
| 603367 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.2% | 1.6% | 2.7% |
| 1Y | 4.0% | 0.7% | 4.6% |
Return vs Industry: 603367 exceeded the CN Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: 603367 matched the CN Market which returned 4.6% over the past year.
Price Volatility
| 603367 volatility | |
|---|---|
| 603367 Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in CN Market | 11.4% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 603367 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603367's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 3,402 | Zhenxin Du | www.lkcisen.com |
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company’s chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd.
Cisen Pharmaceutical Co., Ltd. Fundamentals Summary
| 603367 fundamental statistics | |
|---|---|
| Market cap | CN¥6.05b |
| Earnings (TTM) | CN¥527.50m |
| Revenue (TTM) | CN¥4.31b |
11.5x
P/E Ratio1.4x
P/S RatioIs 603367 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603367 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.31b |
| Cost of Revenue | CN¥1.80b |
| Gross Profit | CN¥2.52b |
| Other Expenses | CN¥1.99b |
| Earnings | CN¥527.50m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 29, 2024
| Earnings per share (EPS) | 1.17 |
| Gross Margin | 58.34% |
| Net Profit Margin | 12.23% |
| Debt/Equity Ratio | 1.8% |
How did 603367 perform over the long term?
See historical performance and comparison